ATE119781T1 - Antikoagulanszubereitung. - Google Patents

Antikoagulanszubereitung.

Info

Publication number
ATE119781T1
ATE119781T1 AT91912208T AT91912208T ATE119781T1 AT E119781 T1 ATE119781 T1 AT E119781T1 AT 91912208 T AT91912208 T AT 91912208T AT 91912208 T AT91912208 T AT 91912208T AT E119781 T1 ATE119781 T1 AT E119781T1
Authority
AT
Austria
Prior art keywords
epi
increase
anticoagulant preparation
anticoagulant
preparation
Prior art date
Application number
AT91912208T
Other languages
English (en)
Inventor
Ole Juul Nordfang
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE119781T1 publication Critical patent/ATE119781T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Shaping By String And By Release Of Stress In Plastics And The Like (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Materials For Medical Uses (AREA)
AT91912208T 1990-06-19 1991-05-30 Antikoagulanszubereitung. ATE119781T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK148890A DK148890D0 (da) 1990-06-19 1990-06-19 Farmaceutisk praeparat

Publications (1)

Publication Number Publication Date
ATE119781T1 true ATE119781T1 (de) 1995-04-15

Family

ID=8105367

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91912208T ATE119781T1 (de) 1990-06-19 1991-05-30 Antikoagulanszubereitung.

Country Status (11)

Country Link
EP (1) EP0535129B1 (de)
JP (1) JP3362038B2 (de)
AT (1) ATE119781T1 (de)
AU (1) AU645581B2 (de)
BG (1) BG61181B1 (de)
CA (1) CA2085101A1 (de)
DE (1) DE69108242T2 (de)
DK (2) DK148890D0 (de)
ES (1) ES2069894T3 (de)
HU (1) HU221323B1 (de)
WO (1) WO1991019514A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849703A (en) * 1990-08-27 1998-12-15 G. D. Searle & Co. Pre-formed anticoagulant heparin/TFPI complexes
US6291427B1 (en) 1990-08-27 2001-09-18 G.D. Searle & Co. Anticoagulant combination of LACI and sulfated polysaccharides
DK261490D0 (da) * 1990-10-31 1990-10-31 Novo Nordisk As New pharmaceutical compound
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US6063764A (en) * 1992-06-01 2000-05-16 Washington University & Chiron Corp. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US20030171292A1 (en) 1992-06-01 2003-09-11 Creasey Abla A. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
WO1993025230A1 (en) * 1992-06-11 1993-12-23 G.D. Searle & Co. Prophylaxis and treatment of sepsis and sepsis-associated coagulation disorders
IL108798A0 (en) * 1993-03-02 1994-06-24 Novo Nordisk As Non-glycosylated tfpi analogues
US5981471A (en) * 1997-02-06 1999-11-09 Entremed, Inc. Compositions and methods for inhibiting cellular proliferation
IL161407A0 (en) 2001-10-15 2004-09-27 Chiron Corp Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0048898B1 (de) * 1980-09-30 1985-04-17 Bayer Ag Verfahren zur Herstellung eines Antithrombin-Heparin-Komplexes sowie diesen Komplex enthaltende pharmazeutische Mischungen
US4689323A (en) * 1983-09-26 1987-08-25 Miles Laboratories, Inc. Covalently bound heparin--antithrombin-III complex
IL79255A0 (en) * 1986-06-26 1986-09-30 Hadassah Med Org Composition for metastasis prevention
US4900723A (en) * 1988-04-29 1990-02-13 E. R. Squibb & Sons, Inc. Method of preventing or reducing venous thrombosis using a thromboxane A2 receptor antagonist in conjunction with heparin and combination
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner

Also Published As

Publication number Publication date
BG61181B1 (bg) 1997-02-28
DE69108242D1 (de) 1995-04-20
AU8060491A (en) 1992-01-07
JP3362038B2 (ja) 2003-01-07
DE69108242T2 (de) 1995-07-06
CA2085101A1 (en) 1991-12-20
EP0535129B1 (de) 1995-03-15
EP0535129A1 (de) 1993-04-07
JPH05507926A (ja) 1993-11-11
WO1991019514A1 (en) 1991-12-26
HU9204036D0 (en) 1993-03-29
BG97199A (bg) 1993-12-24
HU221323B1 (en) 2002-09-28
DK0535129T3 (da) 1995-08-07
HUT63578A (en) 1993-09-28
DK148890D0 (da) 1990-06-19
AU645581B2 (en) 1994-01-20
ES2069894T3 (es) 1995-05-16

Similar Documents

Publication Publication Date Title
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
FI931097A0 (fi) Laekemedel, deras framstaellning och anvaendning vid bekaempning av smaertor och/eller inflammationen hos maenniskor och djur
MX9603925A (es) Combinaciones de anticoagulantes y proteinas activas tromboliticamente, y usos de las mismas.
ATE119781T1 (de) Antikoagulanszubereitung.
HU9301253D0 (en) Medical preparative applicable for treatment of enlarged time of coagulation
DK0910428T3 (da) Fotoferesebehandling af kroniske HCV-infektioner
TR200002078T2 (tr) Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.
ATE311191T1 (de) Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen
ES2055314T3 (es) Tratamiento de disfuncion leucocitaria con gm-csf.
ES2107414T3 (es) Utilizacion de interferon-beta humano para la estimulacion de la eritropoyesis.
DK0651654T3 (da) Anvendelse af lysozymdimer til fremstilling af et lægemiddel til styrkelse af de naturlige forsvarsmekanismer
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
DK225689D0 (da) Anvendelse af metalloporphyriner til modvirkning af den toksiske virkning af tumorterapi
ATE458495T1 (de) Therapeutische zubereitung für autoimmune erkrankungen
RU92016457A (ru) Антикоагулирующий препарат
EP0340933A3 (de) Heparin enthaltende Formulierungen
SE9003181D0 (sv) Use of heparin fraction
DK0515550T3 (da) Heparinneutralisation med blodpladefaktor 4
Balas et al. Venous Thrombosis in Childhood
Huet et al. Subcutaneous enoxaparin as anticoagulant therapy in acute pulmonary embolism in man
UA7180C2 (uk) Препарат для лікування та профілактики атерогенних дисліпопротеїнемій та синдрому гіперкоагуляції

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee